Table 3.

Comparison of SCORE2 risk categories in patients and controls.

Risk Category	Psoriasis Patients	Controls	Difference Testing
	%, n	%, n	Chi2 Value	p Value
Age < 50 years
Low risk <2.5%	60.8 (45)	86.4 (38)		0.010
Moderate risk 2.5 to <7.5%	33.8 (28)	13.6 (6)	9.203
High risk ≥7.5%	5.4 (4)	0.0 (0)
Age 50–69 years
Low risk <2.5%	2.6 (1)	0.0 (0)		0.092
Moderate risk 5–10%	65.8 (25)	90.9 (20)	4.771
High risk ≥10%	31.6 (12)	9.1 (2)